Work

Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor

Year: 2012

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2012.03.088

Authors: Bruce J. Melancon, Rocco D. Gogliotti, James C. Tarr, Sam A. Saleh, Brian A. Chauder, Evan P. Lebois, Hyekyung P. Cho, Thomas J. Utley, Douglas J. Sheffler, Thomas M. Bridges, Ryan D. Morrison, J. Scott Daniels, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Michael R. Wood

Institutions: Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Receptor Mechanisms and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Vanderbilt University, National Institutes of Health, National Institute of Mental Health

Awards: G1453181953, G2418000010, G2471675597, G2478413624, The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, G663594137, Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia

OpenAlex ID: W1979142121

FWCI: 1.277

Cites: 13

Cited by: 17

Related to: 10